Patents Assigned to ARRINEX, INC.
-
Patent number: 12256981Abstract: Apparatus and methods for treating conditions such as rhinitis are disclosed herein where a distal end of a probe shaft is introduced through the nasal cavity where the distal end has an end effector with a first configuration having a low-profile which is shaped to manipulate tissue within the nasal cavity. The distal end may be positioned into proximity of a tissue region having a post nasal nerve associated with a middle or inferior nasal turbinate. Once suitably positioned, the distal end may be reconfigured from the first configuration to a second configuration which is shaped to contact and follow the tissue region and the post nasal nerve may then be ablated via the distal end. Ablation may be performed using various mechanisms, such as cryotherapy, and optionally under direct visualization.Type: GrantFiled: May 30, 2023Date of Patent: March 25, 2025Assignee: Arrinex, Inc.Inventor: Vahid Saadat
-
Patent number: 12257001Abstract: The invention disclosed here generally relates to devices used to identify the location of a never in order to modify a property of the nerve. Specifically, the invention utilized pre-operative scans of a patient's nasal cavity in order to identify target treatment locations when a nerve to be treated is located. The image of the nasal cavity and target treatment location can be registered with the real time position of the nasal cavity using a surgical navigation system in order to assist in guiding a surgical probe to the target treatment location.Type: GrantFiled: January 25, 2021Date of Patent: March 25, 2025Assignee: Arrinex, Inc.Inventors: Vahid Saadat, William Jason Fox, Mojgan Saadat
-
Patent number: 12232799Abstract: Systems and related methods for identifying and/or ablating targeted nerves are provided. A probe with stimulating electrodes and/or ablation members are provided. The probe may be inserted into a nasal cavity and current may be introduced through the electrodes to stimulate a targeted area. The response to stimulation may be used to identify the targeted nerve. Once identified, the ablation member may ablate the targeted nerve.Type: GrantFiled: September 18, 2023Date of Patent: February 25, 2025Assignee: Arrinex, Inc.Inventors: William Jason Fox, David Moosavi, Mojgan Saadat, Vahid Saadat, Caroline Sobek, Neekon Saadat
-
Patent number: 12193883Abstract: Devices and methods for treating rhinitis are described where the devices are configured to ablate a single nerve branch or multiple nerve branches of the posterior nasal nerves located within the nasal cavity. A surgical probe may be inserted into the sub-mucosal space of a lateral nasal wall and advanced towards a posterior nasal nerve associated with a middle nasal turbinate or an inferior nasal turbinate into a position proximate to the posterior nasal nerve where neuroablation of the posterior nasal nerve may be performed with the surgical probe. The probe device may utilize a visible light beacon that provides trans-illumination of the sub-mucosal tissue or an expandable structure disposed in the vicinity of the distal end of the probe shaft to enable the surgeon to visualize the sub-mucosal position of the distal end of the surgical probe from inside the nasal cavity using, e.g., an endoscope.Type: GrantFiled: October 8, 2019Date of Patent: January 14, 2025Assignee: Arrinex, Inc.Inventors: Bryant Lin, David Moosavi, Mojgan Saadat, Vahid Saadat
-
Patent number: 12161380Abstract: The invention disclosed here generally relates to devices that can modify a property of a nerve. Specifically, the subject invention is contemplated to modify the posterior nasal nerve signal conduction in such a way so as to reduce the signals transmitted to the nasal cavity. Reduction or interruption of the nerve signals results in the reduction of the distal organ activity. In particular, embodiments of the present invention allow for increased lateral contact or apposition of the target tissue region having at least one posterior nasal nerve with the end effector surface by lateral and/or longitudinal translation of the end effector relative to the surgical probe shaft. This improved lateral surface contact has several benefits, including improved patient outcomes and patient safety as the end effector is adequately in contact with target tissue for subsequent ablation therapy.Type: GrantFiled: April 28, 2021Date of Patent: December 10, 2024Assignee: Arrinex, Inc.Inventors: Vahid Saadat, William Jason Fox, Mojgan Saadat
-
Patent number: 11986232Abstract: The present disclosure provides apparatuses and methods for treating conditions such as chronic daily headache, cluster headache, tension headache, migraine, or acute headache of a patient. In example methods, a cryotherapy element is introduced into the nasal cavity or pterygopalatine fossa to cool or cryoablate at least one of a nasal nerve tissue or nasal blood vessel. The cryotherapy element may be introduced into the nasal cavity in a collapsed position, and prior to cooling a target treatment site may be expanded to an expanded configuration.Type: GrantFiled: July 22, 2019Date of Patent: May 21, 2024Assignee: Arrinex, Inc.Inventors: Brian Fahey, William Jason Fox, Bryant Lin, Vahid Saadat
-
Patent number: 11786292Abstract: Systems and related methods for identifying and/or ablating targeted nerves are provided. A probe with stimulating electrodes and/or ablation members are provided. The probe may be inserted into a nasal cavity and current may be introduced through the electrodes to stimulate a targeted area. The response to stimulation may be used to identify the targeted nerve. Once identified, the ablation member may ablate the targeted nerve.Type: GrantFiled: January 14, 2022Date of Patent: October 17, 2023Assignee: Arrinex, Inc.Inventors: William Jason Fox, David Moosavi, Mojgan Saadat, Vahid Saadat, Caroline Sobek, Neekon Saadat
-
Patent number: 11602260Abstract: Devices and methods for treating rhinitis are provided. An integrated therapy and imaging device is provided for single handheld use. The device may have a hollow elongated cannula, a therapeutic element coupled to a distal portion of the cannula, an imaging assembly coupled to the cannula to provide visualization of the therapeutic element, and an articulating region operably coupled to the imaging assembly to articulate the imaging assembly. The imaging assembly may be articulated so as to translate vertically, laterally, axially, and/or rotationally.Type: GrantFiled: February 13, 2017Date of Patent: March 14, 2023Assignee: Arrinex, Inc.Inventors: Vahid Saadat, Mojgan Saadat, William Jason Fox
-
Patent number: 11576559Abstract: A direct vision cryosurgical and methods of use are described herein where the device may generally comprise an elongated rigid structure with a distal end, a proximal end, and a central lumen. The distal end may comprise a non-coring optically transparent needle tip with at least one lateral fenestration in communication with the central lumen. The distal end may also house at least one imaging device configured for distal imaging. A proximal end of the device may comprise a handle with a means for connecting the imaging device(s) to an imaging display(s), and a means for accessing bodily tissue in the vicinity of the distal end with a cryo-ablation probe through the central lumen and the lateral fenestration(s) for diagnostic or therapeutic purposes.Type: GrantFiled: September 23, 2020Date of Patent: February 14, 2023Assignee: Arrinex, Inc.Inventors: Vahid Saadat, Matthew Herron, Richard C. Ewers
-
Patent number: 11278356Abstract: Apparatus and methods for treating and monitoring conditions such as rhinitis are disclosed herein. The technology utilizes ultrasound scans to identify target treatment sites, and monitor the treatment of a patient undergoing a treatment. The treatment may be an ablation treatment of a nasal nerve, for example the PNN for the treatment of nasal conditions, such as rhinitis. The ultrasound scans are performed within the nasal cavity with an ultrasound probe or a combined ultrasound and ablation probe and may use Doppler, A-mode, B-mode, M-mode or other ultrasound and non-ultrasound modalities to detect and monitor the target treatment sites.Type: GrantFiled: April 30, 2018Date of Patent: March 22, 2022Assignee: Arrinex, Inc.Inventors: Brian Fahey, William Jason Fox, Bryant Lin, Mojgan Saadat, Vahid Saadat
-
Patent number: 11253312Abstract: Systems and related methods for identifying and/or ablating targeted nerves are provided. A probe with stimulating electrodes and/or ablation members are provided. The probe may be inserted into a nasal cavity and current may be introduced through the electrodes to stimulate a targeted area. The response to stimulation may be used to identify the targeted nerve. Once identified, the ablation member may ablate the targeted nerve.Type: GrantFiled: October 17, 2017Date of Patent: February 22, 2022Assignee: Arrinex, Inc.Inventors: William Jason Fox, David Moosavi, Mojgan Saadat, Vahid Saadat, Caroline Sobek, Neekon Saadat
-
Patent number: 11154696Abstract: Surgical devices with integrated visualization and cauterization are described herein where such devices include an elongate structure having a central lumen and an expandable space-creating structure having at least one expandable leaflet mounted in the vicinity of the distal end and is configured for placement within a mammalian body proximate to a therapeutic target. Also included is a proximal terminal having an actuator mounted in the vicinity of the proximal end and is configured to remain outside of said body and provide an actuation mechanism for actuating the space-creating structure. Additionally, at least one fluid connector and said central lumen is in fluid communication between an interior of the expandable space-creating structure and the at least one fluid connector.Type: GrantFiled: December 17, 2018Date of Patent: October 26, 2021Assignee: Arrinex, Inc.Inventor: Vahid Saadat
-
Patent number: 11026738Abstract: The invention disclosed here generally relates to devices that can modify a property of a nerve. Specifically, the subject invention is contemplated to modify the posterior nasal nerve signal conduction in such a way so as to reduce the signals transmitted to the nasal cavity. Reduction or interruption of the nerve signals results in the reduction of the distal organ activity. In particular, embodiments of the present invention allow for increased lateral contact or apposition of the target tissue region having at least one posterior nasal nerve with the end effector surface by lateral and/or longitudinal translation of the end effector relative to the surgical probe shaft. This improved lateral surface contact has several benefits, including improved patient outcomes and patient safety as the end effector is adequately in contact with target tissue for subsequent ablation therapy.Type: GrantFiled: June 15, 2017Date of Patent: June 8, 2021Assignee: Arrinex, Inc.Inventors: Vahid Saadat, William Jason Fox, Mojgan Saadat
-
Patent number: 10939965Abstract: The invention disclosed here generally relates to devices used to identify the location of a never in order to modify a property of the nerve. Specifically, the invention utilized pre-operative scans of a patient's nasal cavity in order to identify target treatment locations when a nerve to be treated is located. The image of the nasal cavity and target treatment location can be registered with the real time position of the nasal cavity using a surgical navigation system in order to assist in guiding a surgical probe to the target treatment location.Type: GrantFiled: July 20, 2017Date of Patent: March 9, 2021Assignee: Arrinex, Inc.Inventors: Vahid Saadat, William Jason Fox, Mojgan Saadat
-
Patent number: 10813533Abstract: A direct vision cryosurgical and methods of use are described herein where the device may generally comprise an elongated rigid structure with a distal end, a proximal end, and a central lumen. The distal end may comprise a non-coring optically transparent needle tip with at least one lateral fenestration in communication with the central lumen. The distal end may also house at least one imaging device configured for distal imaging. A proximal end of the device may comprise a handle with a means for connecting the imaging device(s) to an imaging display(s), and a means for accessing bodily tissue in the vicinity of the distal end with a cryo-ablation probe through the central lumen and the lateral fenestration(s) for diagnostic or therapeutic purposes.Type: GrantFiled: November 6, 2017Date of Patent: October 27, 2020Assignee: Arrinex, Inc.Inventors: Vahid Saadat, Matthew Herron, Richard C. Ewers
-
Patent number: 10512498Abstract: Apparatus and methods for treating conditions such as rhinitis are disclosed herein where a distal end of a probe shaft is introduced through the nasal cavity where the distal end has an end effector with a first configuration having a low-profile which is shaped to manipulate tissue within the nasal cavity. The distal end may be positioned into proximity of a tissue region having a post nasal nerve associated with a middle or inferior nasal turbinate. Once suitably positioned, the distal end may be reconfigured from the first configuration to a second configuration which is shaped to contact and follow the tissue region and the post nasal nerve may then be ablated via the distal end. Ablation may be performed using various mechanisms, such as cryotherapy, and optionally under direct visualization.Type: GrantFiled: July 2, 2018Date of Patent: December 24, 2019Assignee: Arrinex, Inc.Inventor: Vahid Saadat
-
Patent number: D933816Type: GrantFiled: July 9, 2019Date of Patent: October 19, 2021Assignee: Arrinex, Inc.Inventors: William Jason Fox, Vahid Saadat, David Moosavi, Sherwin Llamido, Roman Turovskiy, William Gould, Matt Allison Herron
-
Patent number: D940856Type: GrantFiled: September 15, 2021Date of Patent: January 11, 2022Assignee: Arrinex, Inc.Inventors: William Jason Fox, Vahid Saadat, David Moosavi, Sherwin Llamido, Roman Turovskiy, William Gould, Matt Allison Herron
-
Patent number: D969318Type: GrantFiled: July 9, 2019Date of Patent: November 8, 2022Assignee: Arrinex, Inc.Inventors: William Jason Fox, Vahid Saadat, David Moosavi, Sherwin Llamido, Roman Turovskiy, William Gould, Matt Allison Herron
-
Patent number: D990678Type: GrantFiled: October 4, 2022Date of Patent: June 27, 2023Assignee: Arrinex, Inc.Inventors: William Jason Fox, Vahid Saadat, David Moosavi, Sherwin Llamido, Roman Turovskiy, William Gould, Matt Allison Herron